Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

money-pills-pharma-file

GSK settles first Zantac lawsuit due for trial in US

June 23, 2023 Medical Communications Cancer, GSK, Pharmacy, Zantac, lawsuit

UK-based pharmaceutical and biotechnology company GSK has reached a settlement with a US man who claims the drugmaker’s heartburn medicine …
News

FDA approves new medicines to treat paediatric type 2 diabetes

June 22, 2023 Medical Communications Diabetes, FDA, Synjardy, jardiance, paediatrics, type 2 diabetes

The US Food and Drug Administration (FDA) has announced that it has approved Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin …
News
national-cancer-institute-kmvohcb-w5g-unsplash_1

FDA approves Pfizer’s HRR mCRPC drug

June 21, 2023 Medical Communications FDA, Oncology, Pfizer, breast cancer, oncology, prostate cancer

US-based pharmaceutical and biotechnology company Pfizer has announced that the US Food and Drug Administration (FDA) has approved its homologous …
News

PharmaTher and Vitruvias sign collaboration agreement to commercialise ketamine-based treatment in the US

June 21, 2023 Medical Communications Ketamine, Neurology, PharmaTher, Vitruvias, commercialisation

Specialty pharmaceutical companies, Canadian PharmaTher and US-based Vitruvias, have entered into a commercialisation partnership to bring Ketarx products to the …
News

Abu Dhabi’s Department of Health, M42 and AbbVie enter strategic partnership

June 20, 2023 Medical Communications AbbVie, Abu Dhabi, DoH, M42, Oncology, strategic partnership

Abu Dhabi’s Department of Health (DoH) has signed a Memorandum of Understanding (MoU) with AbbVie and M42 to advance research …
News

GSK announces extension of FDA’s review for momelotinib

June 20, 2023 Medical Communications FDA, GSK, Oncology, momelotinib, new drug application

GSK has announced that the US Food and Drug Administration (FDA) has extended its review period for the new drug …
News

Santhera and Catalyst Pharmaceuticals sign $231m license and collaboration deal

June 20, 2023 Medical Communications Catalyst Pharmaceuticals, Rare Diseases, Vamorolone, licence and collaboration, santhera

Swiss specialty pharmaceutical company Santhera and US-based biopharmaceutical company Catalyst Pharmaceuticals have announced that they have signed an exclusive license …
News

Rani Therapeutics’ oral ‘robotic pill’ delivers injection trans-enterically

June 19, 2023 Medical Communications Osteoporosis, Rani Therapeutics, injection, osteoporosis, robotic pill, robotics

US Rani Therapeutics, a clinical-stage biotherapeutics company, has reported new results from its phase 1 trial into the RaniPill capsule …
News

Inventiva and Echosens collaborate to bring awareness to NASH and encourage screening for at-risk patients

June 8, 2023 Medical Education Echosens, Hepatology, Inventiva, liver disease, nash, non-alcoholic steatohepatitis

French clinical stage biopharmaceutical company Inventiva has announced a collaboration with US-based high-technology company Echosens to bring attention to, and …
News
1200px-vaccine_image_1

GSK’s RSV vaccine approved in EU for older adults

June 7, 2023 Medical Communications EU, GSK, Infections and infestations, RSV, Vaccine

GSK has announced that the European Commission (EC) has authorised Arexvy, the company’s respiratory syncytial virus (RSV) vaccine for active …
News

Bellerophon shares top-line data from phase 3 trial of INOpulse for fILD

June 6, 2023 Medical Communications Bellerophon Therapeutics, Cardiology, clinical trials, fibrotic interstitial lung disease

Bellerophon Therapeutics has announced top-line results from its phase 3 REBUILD trial evaluating the safety and efficacy of INOpulse for …
News

Quanticate announces strategic partnership with KPS Life

June 5, 2023 Medical Communications KPS Life, Pharmacy, Quanticate, fsp

Global biometric clinical research group Quanticate has announced a strategic partnership with US-based provider of functional service provision (FSP) solutions …
News

NICE approves first treatment for obstructive HCM for NHS use

June 2, 2023 Medical Communications Bristol-Myers Squibb, Cardiology, NHS, NICE, obstructive HCM

The National Institute for Health and Care Excellence (NICE) has announced that it has approved mavacamten (Camzyos) for the treatment …
News

NICE recommends Pfizer’s rimegepant for preventing episodic migraine attacks

June 2, 2023 Medical Communications NHS, NICE, Neurology, Pfizer, migraine

The National Institute for Health and Care Excellence (NICE) has announced that it has recommended an oral treatment for the …
News
towfiqu-barbhuiya-hn2hqoalbck-unsplash_1

European Parliament shares goal to tackle antimicrobial resistance

June 2, 2023 Medical Communications EU, European Parliament, Microbiology, antimicrobial resistance

The European Parliament has shared its recommendations for a “coordinated EU response to health threats posed by antimicrobial resistance,” according …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025